Cargando…

Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors

Corona Virus Disease 2019 (COVID-19) continues to be a burden for human health since its outbreak in Wuhan, China in December 2019. Recently, the emergence of new variants of concerns (VOCs) is challenging for vaccines and drugs efficiency. In severe cases, SARS-CoV-2 provokes inappropriate hyperinf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diarimalala, Rominah Onintsoa, Wei, Yanhong, Hu, Da, Hu, Kanghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288989/ https://www.ncbi.nlm.nih.gov/pubmed/37360532 http://dx.doi.org/10.3389/fcimb.2023.1218039

Ejemplares similares

Recent advances of enterovirus 71 [Formula: see text] targeting Inhibitors
por: Diarimalala, Rominah Onintsoa, et al.
Publicado: (2020)

EV-A71 Mechanism of Entry: Receptors/Co-Receptors, Related Pathways and Inhibitors
por: Hu, Kanghong, et al.
Publicado: (2023)

BPOZ-2 is a negative regulator of the NLPR3 inflammasome contributing to SARS-CoV-2-induced hyperinflammation
por: Li, Jingfei, et al.
Publicado: (2023)

Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
por: Diesendorf, Viktoria, et al.
Publicado: (2023)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern
por: Vanhulle, Emiel, et al.
Publicado: (2022)

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
por: Wang, Mei-Yue, et al.
Publicado: (2020)

Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review
por: He, Weihang, et al.
Publicado: (2022)

SARS-CoV-2: The Monster Causes COVID-19
por: Song, Chang, et al.
Publicado: (2022)

SARS-CoV-2: Origin, Evolution, and Targeting Inhibition
por: Ning, Shuo, et al.
Publicado: (2021)

Distinct Metagenomic Signatures in the SARS-CoV-2 Infection
por: Liu, Yijun, et al.
Publicado: (2021)

Evaluating the effect of SARS-CoV-2 spike mutations with a linear doubly robust learner
por: Wang, Xin, et al.
Publicado: (2023)

Stability of SARS-CoV-2 in cold-chain transportation environments and the efficacy of disinfection measures
por: Peng, Shuyi, et al.
Publicado: (2023)

SARS-CoV-2 in Pregnant Women: Consequences of Vertical Transmission
por: Chaubey, Ishaan, et al.
Publicado: (2021)

SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
por: Liu, Fengming, et al.
Publicado: (2021)

SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2021)

microRNA, the Innate-Immune System and SARS-CoV-2
por: Hill, James M., et al.
Publicado: (2022)

Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador
por: Guevara, Rommel, et al.
Publicado: (2022)

SARS-CoV-2 induced hepatic injuries and liver complications
por: Saeed, Umar, et al.
Publicado: (2022)

Choosing a cellular model to study SARS-CoV-2
por: Pires De Souza, Gabriel Augusto, et al.
Publicado: (2022)

Structure-Based Primer Design Minimizes the Risk of PCR Failure Caused by SARS-CoV-2 Mutations
por: Dong, Hongjie, et al.
Publicado: (2021)

Improving Detection Efficiency of SARS-CoV-2 Nucleic Acid Testing
por: Zhang, Jie, et al.
Publicado: (2020)

Characteristics of COVID-19 Patients With SARS-CoV-2 Positivity in Feces
por: Wu, Wenrui, et al.
Publicado: (2022)

SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles
por: Mishra, Tarun, et al.
Publicado: (2021)

Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells
por: Shaharuddin, Syairah Hanan, et al.
Publicado: (2021)

Corrigendum: SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Evidence of Infection of Human Embryonic Stem Cells by SARS-CoV-2
por: Zeng, Weijie, et al.
Publicado: (2022)

The Differentiation and Maintenance of SARS-CoV-2-Specific Follicular Helper T Cells
por: Wang, Yifei, et al.
Publicado: (2022)

Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection
por: Deroubaix, Aurélie, et al.
Publicado: (2022)

The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection
por: Romani, Lorenza, et al.
Publicado: (2022)

Host mitochondria: more than an organelle in SARS-CoV-2 infection
por: Shoraka, Shahrzad, et al.
Publicado: (2023)

Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota
por: Tieu, Vivian, et al.
Publicado: (2023)

Metatranscriptomic analysis revealed Prevotella as a potential biomarker of oropharyngeal microbiomes in SARS-CoV-2 infection
por: Lu, Sifen, et al.
Publicado: (2023)

Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
por: Hu, Caiqin, et al.
Publicado: (2022)

Development of an Adeno-Associated Virus-Vectored SARS-CoV-2 Vaccine and Its Immunogenicity in Mice
por: Qin, Xi, et al.
Publicado: (2022)

Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2
por: Alam, Intikhab, et al.
Publicado: (2020)

In silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs
por: Periwal, Neha, et al.
Publicado: (2022)

Biofilms possibly harbor occult SARS-CoV-2 may explain lung cavity, re-positive and long-term positive results
por: He, Daqian, et al.
Publicado: (2022)

Is the “Common Cold” Our Greatest Ally in the Battle Against SARS-CoV-2?
por: Capoor, Manu N., et al.
Publicado: (2020)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
por: Quinti, Isabella, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1faei4cb1h5t8m0qv8a7hpu6gg